Vera Therapeutics Inc (VERA)
37.98
+1.03
(+2.79%)
USD |
NASDAQ |
May 31, 16:00
37.98
0.00 (0.00%)
After-Hours: 20:00
Vera Therapeutics Free Cash Flow: -99.72M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -99.72M |
| December 31, 2023 | -92.18M |
| September 30, 2023 | -88.20M |
| June 30, 2023 | -83.65M |
| March 31, 2023 | -84.91M |
| December 31, 2022 | -67.66M |
| September 30, 2022 | -52.93M |
| Date | Value |
|---|---|
| June 30, 2022 | -39.96M |
| March 31, 2022 | -28.59M |
| December 31, 2021 | -23.71M |
| September 30, 2021 | -44.65M |
| June 30, 2021 | -41.62M |
| March 31, 2021 | -36.67M |
| December 31, 2020 | -34.91M |
Free Cash Flow Range, Past 5 Years
-99.72M
Minimum
Mar 2024
-23.71M
Maximum
Dec 2021
-58.52M
Average
-48.79M
Median
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals Inc | 3.479B |
| Alpine Immune Sciences Inc (DELISTED) | -80.96M |
| Fate Therapeutics Inc | -139.78M |
| Mersana Therapeutics Inc | -173.92M |
| Equillium Inc | -22.66M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -33.83M |
| Cash from Investing (Quarterly) | -219.29M |
| Cash from Financing (Quarterly) | 276.54M |
| Free Cash Flow Per Share (Quarterly) | -0.6637 |
| Free Cash Flow Yield | -5.71% |